First published on 29 Jul 2019
Latest NHS briefing on best value biologicals: adalimumab update 6
This latest briefing provides: Clinical advice when a patient needs to switch from the selected biosimilar to an alternative product Data on the uptake of biosimilars by region (at the end of May 2019) An update on the procurement process […]